About this Journal Submit a Manuscript Table of Contents
Cholesterol
Volume 2013 (2013), Article ID 314170, 7 pages
http://dx.doi.org/10.1155/2013/314170
Clinical Study

Short-Term Effect of Pitavastatin Treatment on Glucose and Lipid Metabolism and Oxidative Stress in Fasting and Postprandial State Using a Test Meal in Japanese Men

1Kakuda Clinic, Takamatsu Na15-1, Kahoku, Ishikawa 929-1215, Japan
2Department of General Medicine, Kanazawa Medical University, 1-1 Daigaku Uchinada, Kahoku, Ishikawa Prefecture 920-0293, Japan
3Kanazawa Medical University, 1-1 Daigaku Uchinada, Kahoku, Ishikawa Prefecture 920-0293, Japan

Received 3 September 2013; Revised 10 November 2013; Accepted 12 November 2013

Academic Editor: Jeffrey Cohn

Copyright © 2013 Hirokazu Kakuda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Hirokazu Kakuda, Junji Kobayashi, Masahiro Kakuda, Junichi Yamakawa, and Noboru Takekoshi, “The effect of anagliptin treatment on glucose metabolism and lipid metabolism, and oxidative stress in fasting and postprandial states using a test meal in Japanese men with type 2 diabetes,” Endocrine, 2014. View at Publisher · View at Google Scholar
  • Anette Varbo, and Børge G. Nordestgaard, “Remnant cholesterol and ischemic heart disease,” Current Opinion in Lipidology, vol. 25, no. 4, pp. 266–273, 2014. View at Publisher · View at Google Scholar
  • Kavita Kulavarasalingam, and Deepak Bhatnagar, “Interaction between carbohydrates and lipid metabolism,” Current Opinion in Lipidology, vol. 25, no. 5, pp. 401–403, 2014. View at Publisher · View at Google Scholar
  • V Barrios, and C Escobar, “Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes,” Future Cardiology, 2016. View at Publisher · View at Google Scholar
  • T. D. Filippatos, and M. S. Elisaf, “Pitavastatin and carbohydrate metabolism: what is the evidence?,” Expert Review of Clinical Pharmacology, pp. 1–6, 2016. View at Publisher · View at Google Scholar
  • Leonardo Roever, “Pitavastatin versus Pravastatin in Reduction of Remnant Lipoprotein Cholesterol in Patients with Dyslipidemias,” Clinical Therapeutics, 2016. View at Publisher · View at Google Scholar
  • P. Elliott Miller, Seth S. Martin, Parag H. Joshi, Steven R. Jones, Joseph M. Massaro, Ralph B. D’Agostino, Craig A. Sponseller, and Peter P. Toth, “Pitavastatin 4 mg Provides Significantly Greater Reduction in Remnant Lipoprotein Cholesterol Compared With Pravastatin 40 mg: Results from the Short-Term Phase IV PREVAIL US Trial in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia,” Clinical Therapeutics, 2016. View at Publisher · View at Google Scholar